ACM
American Capital Management’s DexCom DXCM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31M | Sell |
355,573
-45,220
| -11% | -$3.95M | 1.29% | 28 |
|
2025
Q1 | $27.4M | Buy |
400,793
+94,789
| +31% | +$6.47M | 1.11% | 34 |
|
2024
Q4 | $23.8M | Sell |
306,004
-47,795
| -14% | -$3.72M | 0.89% | 38 |
|
2024
Q3 | $23.7M | Sell |
353,799
-3,007
| -0.8% | -$202K | 0.78% | 37 |
|
2024
Q2 | $40.5M | Buy |
356,806
+1,260
| +0.4% | +$143K | 1.35% | 27 |
|
2024
Q1 | $49.3M | Sell |
355,546
-7,842
| -2% | -$1.09M | 1.58% | 23 |
|
2023
Q4 | $45.1M | Buy |
363,388
+41,539
| +13% | +$5.15M | 1.54% | 22 |
|
2023
Q3 | $30M | Buy |
321,849
+31,238
| +11% | +$2.91M | 1.16% | 29 |
|
2023
Q2 | $37.3M | Sell |
290,611
-2,213
| -0.8% | -$284K | 1.3% | 25 |
|
2023
Q1 | $34M | Buy |
292,824
+10,207
| +4% | +$1.19M | 1.2% | 26 |
|
2022
Q4 | $32M | Buy |
282,617
+1,943
| +0.7% | +$220K | 1.25% | 25 |
|
2022
Q3 | $22.6M | Sell |
280,674
-894
| -0.3% | -$72K | 0.89% | 34 |
|
2022
Q2 | $21M | Buy |
281,568
+211,759
| +303% | +$15.8M | 0.79% | 34 |
|
2022
Q1 | $35.7M | Buy |
69,809
+1,844
| +3% | +$943K | 1.05% | 30 |
|
2021
Q4 | $36.5M | Sell |
67,965
-236
| -0.3% | -$127K | 0.94% | 33 |
|
2021
Q3 | $37.3M | Sell |
68,201
-704
| -1% | -$385K | 1% | 33 |
|
2021
Q2 | $29.4M | Buy |
68,905
+9,953
| +17% | +$4.25M | 0.82% | 34 |
|
2021
Q1 | $21.2M | Buy |
58,952
+15,450
| +36% | +$5.55M | 0.64% | 39 |
|
2020
Q4 | $16.1M | Buy |
43,502
+13,976
| +47% | +$5.17M | 0.48% | 42 |
|
2020
Q3 | $12.2M | Buy |
29,526
+432
| +1% | +$178K | 0.45% | 41 |
|
2020
Q2 | $11.8M | Buy |
29,094
+436
| +2% | +$177K | 0.43% | 44 |
|
2020
Q1 | $7.72M | Buy |
+28,658
| New | +$7.72M | 0.38% | 45 |
|